Hemostemix Stock Analysis

Hemostemix Stock Analysis Notes

The company recorded a loss per share of 0.02. Hemostemix last dividend was issued on the 30th of December 2020. The entity had 1:20 split on the 30th of December 2020. Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions in Canada. It is also developing various types of cells products, such as synergetic cell precursors, myocardial cell precursors, and neural cell precursors. HEMOSTEMIX INC is traded on TSX Venture Exchange in Canada. To learn more about Hemostemix call the company at 905-580-4170 or check out https://hemostemix.com.

Hemostemix Investment Alerts

Hemostemix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hemostemix's market, we take the total number of its shares issued and multiply it by Hemostemix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hemostemix Profitablity

Management Efficiency

Hemostemix has return on total asset (ROA) of (3.4924) % which means that it has lost $3.4924 on every $100 spent on assets. This is way below average. Hemostemix's management efficiency ratios could be used to measure how well Hemostemix manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hemostemix's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 0.36 in 2024, whereas Return On Tangible Assets are likely to drop (8.37) in 2024. Debt To Assets is likely to climb to 14.46 in 2024, whereas Total Assets are likely to drop slightly above 298.1 K in 2024.

Technical Drivers

As of the 24th of November, Hemostemix retains the Risk Adjusted Performance of 0.1098, market risk adjusted performance of (2.74), and Downside Deviation of 13.29. Hemostemix technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hemostemix jensen alpha, as well as the relationship between the potential upside and skewness to decide if Hemostemix is priced fairly, providing market reflects its last-minute price of 0.08 per share.

Hemostemix Price Movement Analysis

Hemostemix Outstanding Bonds

Hemostemix Predictive Daily Indicators

Hemostemix Forecast Models

Hemostemix's time-series forecasting models are one of many Hemostemix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hemostemix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hemostemix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hemostemix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hemostemix. By using and applying Hemostemix Stock analysis, traders can create a robust methodology for identifying Hemostemix entry and exit points for their positions.

When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.